Your browser doesn't support javascript.
loading
Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment.
Betrian, S; Ysebaert, L; Heider, K H; Delord, J P; Fournié, J J; Quillet-Mary, A.
Affiliation
  • Betrian S; CRCT, Université de Toulouse, CNRS ERL 5294, Inserm U1037, Toulouse, France.
  • Ysebaert L; CRCT, Université de Toulouse, CNRS ERL 5294, Inserm U1037, Toulouse, France.
  • Heider KH; Department of Haematology, Institut Universitaire du Cancer, Toulouse, France.
  • Delord JP; Boehringer Ingelheim RCV GmbH & Co KG, Wien, Austria.
  • Fournié JJ; Institut Universitaire du Cancer, Bureau d'études cliniques, Toulouse, France.
  • Quillet-Mary A; CRCT, Université de Toulouse, CNRS ERL 5294, Inserm U1037, Toulouse, France.
Blood Cancer J ; 6(11): e496, 2016 11 11.
Article in En | MEDLINE | ID: mdl-27834943
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purines / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Drug Resistance, Neoplasm / Quinazolinones / Antibodies, Monoclonal, Humanized / Tetraspanins / Antineoplastic Agents, Immunological / Antigens, Neoplasm Limits: Humans Language: En Journal: Blood Cancer J Year: 2016 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Purines / Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols / Drug Resistance, Neoplasm / Quinazolinones / Antibodies, Monoclonal, Humanized / Tetraspanins / Antineoplastic Agents, Immunological / Antigens, Neoplasm Limits: Humans Language: En Journal: Blood Cancer J Year: 2016 Document type: Article Affiliation country: